CONMED Corporation

NYSE:CNMD 株式レポート

時価総額:US$2.1b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

CONMED 過去の業績

過去 基準チェック /26

CONMEDの収益は年間平均-2.7%の割合で減少していますが、 Medical Equipment業界の収益は年間 増加しています。収益は年間8.7% 7%割合で 増加しています。 CONMEDの自己資本利益率は9.6%であり、純利益率は6.5%です。

主要情報

-2.7%

収益成長率

-4.0%

EPS成長率

Medical Equipment 業界の成長8.9%
収益成長率7.0%
株主資本利益率9.6%
ネット・マージン6.5%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01
There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03
CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

CONMED declares $0.20 dividend

Aug 11

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

Jul 20
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Jun 23
We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Jun 10
Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

収支内訳

CONMED の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NYSE:CNMD 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 241,2628250954
31 Dec 231,2456450553
30 Sep 231,1695848851
30 Jun 231,1398848051
31 Mar 231,099-9446249
31 Dec 221,045-8143947
30 Sep 221,069-8344046
30 Jun 221,042-11442744
31 Mar 221,0206842044
31 Dec 211,0116341544
30 Sep 219896240544
30 Jun 219795439343
31 Mar 218811336940
31 Dec 208621037440
30 Sep 20874036941
30 Jun 20870037342
31 Mar 209513439145
31 Dec 199552938845
30 Sep 199332938344
30 Jun 199012837043
31 Mar 198763136141
31 Dec 188604135338
30 Sep 188407234936
30 Jun 188287334534
31 Mar 188127133732
31 Dec 177965533132
30 Sep 177781532332
30 Jun 177731631832
31 Mar 177691231732
31 Dec 167641531332
30 Sep 167501630631
30 Jun 167351730230
31 Mar 167222229229
31 Dec 157193028727
30 Sep 157233428728
30 Jun 157292729128
31 Mar 157363029627
31 Dec 147403230328
30 Sep 147473131027
30 Jun 147503530827
31 Mar 147533430927
31 Dec 137633631826
30 Sep 137563730826
30 Jun 137604030926

質の高い収益: CNMDは 高品質の収益 を持っています。

利益率の向上: CNMD過去に利益を上げました。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: CNMDの収益は過去 5 年間で年間2.7%減少しました。

成長の加速: CNMDは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。

収益対業界: CNMD昨年収益を上げたため、昨年の収益成長をMedical Equipment業界 ( 2.4% ) と比較することは困難です。


株主資本利益率

高いROE: CNMDの 自己資本利益率 ( 9.6% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘